Oncology PracticeBig changes coming for thyroid cancer stagingAugust 18, 2017Head & Neck/Thyroid Cancers
Hematology TimesFDA approves inotuzumab ozogamicin for rel/ref ALLAugust 18, 2017Leukemia, Myelodysplasia, TransplantationPharmacyALL
Hematology TimesStudy reveals elevated cancer risk in Holocaust survivorsAugust 18, 2017Leukemia, Myelodysplasia, TransplantationRelated Issues
Oncology PracticeObinutuzumab-CHOP not superior to rituximab-CHOP in new DLBCLAugust 17, 2017Lymphoma & Plasma Cell DisordersAggressive LymphomasFollicular Lymphoma
Hematology NewsInotuzumab ozogamicin approved for relapsed/refractory ALLAugust 17, 2017ALLLeukemia, Myelodysplasia, Transplantation
Oncology PracticePhysicians shift on support of single-payer systemAugust 17, 2017Practice ManagementBusiness of Medicine
Hematology TimesNurse education boosts proper use of VTE prophylaxisAugust 17, 2017ThrombosisHematology Nursing
Hematology TimesDrug granted priority review for CTCLAugust 17, 2017Lymphoma & Plasma Cell DisordersNon-Hodgkin Lymphoma
Oncology PracticeFDA advisory committee to consider adjuvant sunitinib for RCCAugust 16, 2017Renal Cell CarcinomaGenitourinary Cancer
Hematology NewsOff-the-shelf T cells used to treat viral infections after HSCTAugust 16, 2017Cellular TherapyPatient & Survivor Care
Hematology TimesLenalidomide maintenance prolongs PFS, OS in MMAugust 16, 2017Multiple MyelomaTransplantation
Hematology TimesPost-approval trials for accelerated drugs fall shortAugust 16, 2017AnemiaLeukemia, Myelodysplasia, TransplantationLymphoma & Plasma Cell DisordersMultiple MyelomaPharmacy
Hematology TimesFDA grants drug orphan designation for AML, CMMLAugust 16, 2017Leukemia, Myelodysplasia, TransplantationAML
